Studies from Harbin Institute of Technology Yield New Data on Personalized Medicine (Meta learning for mutant HLA class I epitope immunogenicity prediction to accelerate cancer clinical immunotherapy)

Press/Media: Press / Media

PeriodDec 27 2024